Heterotopic ossification happens when bone grows outside of its normal location and into the surrounding soft tissues of your body. When this happens, the pieces of bone that develop are called ...
The American Society of Clinical Oncology first published evidence-based practice guidelines for the use of bisphosphonates in breast cancer in 2000 and updated them in 2003. To reflect the proven ...
HO or abnormal bone formation in soft tissues can restrict movement and cause long-term discomfort after surgery or injury. In a new study, researchers have identified two key proteins that help ...
Starting bisphosphonates in women who demonstrate bone destruction through imaging but who have normal plain radiographs is considered reasonable treatment. Starting bisphosphonates in women with only ...
March 2, 2011 — An updated guideline on the use of bone-modifying agents in patients with metastatic breast cancer have been issued by the American Society of Clinical Oncology (ASCO). The guideline ...
Share on Pinterest A study of bone scans is helping scientists determine the prevalence of cardiac amyloidosis. Ben Hasty/MediaNews Group/Reading Eagle via Getty Images Cardiac amyloidosis (CA) causes ...
CHINA, February 9, 2026 /EINPresswire.com/ — Heterotopic ossification (HO), atypical bone formation, causes chronic pain, affecting patient’s quality of life. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results